One-step purification of soluble recombinant human 6-phosphogluconate dehydrogenase from Escherichia coli.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Protein Expression and Purification

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pep.2013.08.017PMID 24018234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycolytic cancer cells lacking 6‐phosphogluconate dehydrogenase metabolize glucose to induce senescence

  2012cited by this paper
• Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.

  2012cited by this paper
• Increased levels of recombinant human proteins with the Escherichia coli strain Rosetta(DE3).

  2010cited by this paper
• Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues.

  2004cited by this paper
• 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes.

  2004cited by this paper
• Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis.

  2003cited by this paper
• Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei.

  2003cited by this paper
• A Colorimetric Assay to Quantify Dehydrogenase Activity in Crude Cell Lysates

  2002cited by this paper
• Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm.

  1999cited by this paper
• 6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species.

  1998cited by this paper
• 6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs.

  1996cited by this paper
• The value of 6-phosphogluconate dehydrogenase (6-PGDH) activity as a marker of tumour cellularity and prognostic indicator in primary breast cancer.

  1986cited by this paper
• Human Brain 6‐Phosphogluconate Dehydrogenase: Purification and Kinetic Properties

  1985cited by this paper
• Purification and properties of 6-phosphogluconate dehydrogenase from rabbit mammary gland.

  1975cited by this paper
• Sheep liver 6-phosphogluconate dehydrogenase: isolation procedure and effect of pH, ionic strength, and metal ions on the kinetic parameters.

  1973cited by this paper
• Sheep liver 6-phosphogluconate dehydrogenase. Inhibition by nucleoside phosphates and by other metabolic intermediates.

  1973cited by this paper

• Cloning, purification, and characterization of the 6-phosphogluconate dehydrogenase (6 PGDH) from Giardia lamblia.

  2021cites this paper
• The Effect of Ozone Treatment on Thermal Burn Wound Healing; An Experimental Study

  2020cites this paper
• Control of the NADPH supply for oxidative stress handling in cancer cells.

  2017cites this paper
• Production of an antioxidative peptide from hairy basil seed waste by a recombinant Escherichia coli

  2016cites this paper